By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biomarkers today said that it will collaborate with India-based Clinigene International on addressing the biomarker and high-end clinical trial services needs of the pharmaceutical and biotech industry.

Seattle-based Pacific Biomarkers provides biomarker and diagnostic assay services. Among Clinigene's services are cell-based assays and immunoanalytical testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.